BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 31608899)

  • 1. Anti-Colorectal Cancer Mechanisms of Formononetin Identified by Network Pharmacological Approach.
    Zhang L; Gong Y; Wang S; Gao F
    Med Sci Monit; 2019 Oct; 25():7709-7714. PubMed ID: 31608899
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Discovery of the Anti-Tumor Mechanism of Calycosin Against Colorectal Cancer by Using System Pharmacology Approach.
    Huang C; Li R; Shi W; Huang Z
    Med Sci Monit; 2019 Jul; 25():5589-5593. PubMed ID: 31352466
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pharmacological Targets and the Biological Mechanisms of Formononetin for Alzheimer's Disease: A Network Analysis.
    Xiao H; Qin X; Wan J; Li R
    Med Sci Monit; 2019 Jun; 25():4273-4277. PubMed ID: 31175839
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pharmacological targets and molecular mechanisms of plumbagin to treat colorectal cancer: A systematic pharmacology study.
    Liang Y; Zhou R; Liang X; Kong X; Yang B
    Eur J Pharmacol; 2020 Aug; 881():173227. PubMed ID: 32505664
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Delineating the underlying molecular mechanisms and key genes involved in metastasis of colorectal cancer via bioinformatics analysis.
    Qi C; Chen Y; Zhou Y; Huang X; Li G; Zeng J; Ruan Z; Xie X; Zhang J
    Oncol Rep; 2018 May; 39(5):2297-2305. PubMed ID: 29517105
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pharmacological biotargets and the molecular mechanisms of oxyresveratrol treating colorectal cancer: Network and experimental analyses.
    Li R; Song Y; Ji Z; Li L; Zhou L
    Biofactors; 2020 Jan; 46(1):158-167. PubMed ID: 31647596
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Anti-colorectal cancer biotargets and biological mechanisms of puerarin: Study of molecular networks.
    Li J; Guo C; Lu X; Tan W
    Eur J Pharmacol; 2019 Sep; 858():172483. PubMed ID: 31233753
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Identification of intestinal flora-related key genes and therapeutic drugs in colorectal cancer.
    Zhang J; Zhang H; Li F; Song Z; Li Y; Zhao T
    BMC Med Genomics; 2020 Nov; 13(1):172. PubMed ID: 33198757
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prediction of novel target genes and pathways involved in bevacizumab-resistant colorectal cancer.
    Makondi PT; Lee CH; Huang CY; Chu CM; Chang YJ; Wei PL
    PLoS One; 2018; 13(1):e0189582. PubMed ID: 29342159
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Anti-cancer targets of formononetin and molecular mechanisms in osteosarcoma: Findings of bioinformatic and experimental assays.
    Hu W; Wu X; Tang J; Zhao G; Xiao N; Zhang L; Li S
    J Cell Mol Med; 2019 May; 23(5):3505-3511. PubMed ID: 30873755
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Identification and Interaction Analysis of Molecular Markers in Colorectal Cancer by Integrated Bioinformatics Analysis.
    Han B; Feng D; Yu X; Zhang Y; Liu Y; Zhou L
    Med Sci Monit; 2018 Aug; 24():6059-6069. PubMed ID: 30168505
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Identification of key genes in colorectal cancer using random walk with restart.
    Cui X; Shen K; Xie Z; Liu T; Zhang H
    Mol Med Rep; 2017 Feb; 15(2):867-872. PubMed ID: 28000901
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Identification of Key Genes in Colorectal Cancer Regulated by miR-34a.
    Wang T; Xu H; Liu X; Chen S; Zhou Y; Zhang X
    Med Sci Monit; 2017 Dec; 23():5735-5743. PubMed ID: 29197895
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Therapeutic targets of vitamin C on liver injury and associated biological mechanisms: A study of network pharmacology.
    Su M; Guo C; Liu M; Liang X; Yang B
    Int Immunopharmacol; 2019 Jan; 66():383-387. PubMed ID: 30530052
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Bioinformatic and experimental data decipher the pharmacological targets and mechanisms of plumbagin against hepatocellular carcinoma.
    Zhou R; Wu K; Su M; Li R
    Environ Toxicol Pharmacol; 2019 Aug; 70():103200. PubMed ID: 31158732
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Functional and protein‑protein interaction network analysis of colorectal cancer induced by ulcerative colitis.
    Dai Y; Jiang JB; Wang YL; Jin ZT; Hu SY
    Mol Med Rep; 2015 Oct; 12(4):4947-58. PubMed ID: 26239378
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Identification of key pathways and genes in colorectal cancer using bioinformatics analysis.
    Liang B; Li C; Zhao J
    Med Oncol; 2016 Oct; 33(10):111. PubMed ID: 27581154
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Weighted gene co-expression network analysis of colorectal cancer liver metastasis genome sequencing data and screening of anti-metastasis drugs.
    Gao B; Shao Q; Choudhry H; Marcus V; Dong K; Ragoussis J; Gao ZH
    Int J Oncol; 2016 Sep; 49(3):1108-18. PubMed ID: 27571956
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Integrated regulatory mechanisms of miRNAs and targeted genes involved in colorectal cancer.
    Wang J; Yu H; Ye L; Jin L; Yu M; Lv Y
    Int J Clin Exp Pathol; 2015; 8(1):517-29. PubMed ID: 25755742
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Identification of Key Candidate Genes and Pathways in Colorectal Cancer by Integrated Bioinformatical Analysis.
    Guo Y; Bao Y; Ma M; Yang W
    Int J Mol Sci; 2017 Mar; 18(4):. PubMed ID: 28350360
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.